1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1: 
Patient demographics, presentation, and vessel and lesion characteristics
Angioplasty Balloon-Mounted Stent Wingspan Stent
Mean age (yr) 64.6 69.1 66.1
Male/female distribution by 159 lesions 26/29 31/8 37/28
Presentation 
    Mean days from first symptom to treatment 69.3 48.5 61.0
    Mean presenting mRS 1.5 1.4 1.6
    Mean stenosis before treatment of 159 primary lesions (%) 83 77 78
    Transient ischemic attack (n = 61) 19 19 23
    Minor stroke (change of 0–1 in mRS, n = 45) 20 9 16
    Major stroke (change of ≥2 in mRS, n = 52) 15 11 26
Vessel and lesion characteristics for all 159 lesions 
    Lesions per device 55 39 65
    <70% stenosis 2 4 7
    ≥70% stenosis 53 35 58
    Perforators 32 13 47
    Nonperforators 23 26 18
    Smooth lesion 31 27 41
    Irregular lesion 17 12 20
    Concentric lesion 20 16 41
    Eccentric lesion 28 23 20
Short lesion (<5 mm) 19 18 22
    Moderate lesion (5–10 mm) 6 11 10
    Long lesion (>10 mm) 23 10 29
Vessel and lesion characteristics for all 209 interventions 
    Interventions per device 89 47 73
    <70% stenosis 9 5 8
    ≥70% stenosis 79 43 65
    Perforators 51 14 54
    Nonperforators 38 33 19
    Smooth lesion 57 33 46
    Irregular lesion 20 15 22
    Concentric lesion 40 21 46
    Eccentric lesion 37 27 22
    Short lesion (<5 mm) 26 20 22
    Moderate lesion (5–10 mm) 9 11 10
    Long lesion (>10 mm) 42 17 36
Activating clotting time at deployment (s) 212 212 217
Duration of procedure (min) 163 149 154